Patents by Inventor Sébastien Bonnel

Sébastien Bonnel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION DRUGS COMPRISING VEGF INHIBITOR AND SERINE PROTEASES/THROMBOLYTIC COMPOUNDS FOR TREATING NEOVASCULAR DISORDERS
    Publication number: 20090285826
    Abstract: Pharmaceutical compositions for inhibiting, preventing or treating unwanted angiogenesis/neovascularization, including that of ocular tissues, contain agents that inhibit VEGF in combination with a second therapy, e.g., that elicited by serine proteases/thrombolytic compounds.
    Type: Application
    Filed: May 4, 2007
    Publication date: November 19, 2009
    Applicants: FOVEA PHARMACEUTICALS SA, FONDATION OPHTHALMOLOGIQUE ADOLPHE DE ROTHSCHILD
    Inventors: Sebastien Bonnel, José Sahel
  • Intraocular transplantation of encapsulated cells
    Patent number: 6267954
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-anglogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: July 31, 2001
    Assignees: Universite de Paris V Rene-Descartes, Association Francaise Retinitis Pigmentosa
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loïc Van Den Berghe, Sébastien Bonnel, Hervé Prats, Jiri Honiger, Martin Neuner-Jehle